Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.4.4 (
adenosine deaminase
)
5,136
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report a new biosensor for
adenosine deaminase
(
ADA
) sensing based on water-soluble conjugated poly(9,9-bis(6'-N,N,N-trimethylammonium)hexyl)fluorine phenylene (PFP) and fluorescence resonance energy transfer technique. In this biosensor, PFP, DNAc-FI labeled with fluorescein (
FAM
), and ethidium bromide (EB) were used as the fluorescence energy donor, resonance gate, and the final fluorescence energy acceptor, respectively. In the absence of
ADA
, the adenosine aptamer forms a hairpin-like conformation with adenosine, which is far from its complementary single-stranded DNA (DNAc-FI). When PFP is excited at 380 nm, fluorescein emits strong green fluorescence via one-step FRET while EB has no fluorescence. After addition of
ADA
, adenosine is hydrolyzed to inosine and then double-stranded DNA (dsDNA) is formed between the aptamer and DNAc-FI, followed by EB intercalating into dsDNA. Once PFP is excited, EB will emit strong yellow fluorescence after two-step FRET from PFP to fluorescein and from fluorescein to EB. The sensitive
ADA
detection then is realized with a low detection limit of 0.5 U/L by measuring the FRET ratio of EB to fluorescein. Most importantly, the assay is accomplished homogeneously in 25 min without further treatments, which is much more simple and rapid than that reported in literature. Hence, this method demonstrates the sensitive, cost-effective, and rapid detection of
ADA
activity. It also opens an opportunity for designing promising sensors for other enzymes.
...
PMID:Water-soluble conjugated polymer as a platform for adenosine deaminase sensing based on fluorescence resonance energy transfer technique. 2489 72
We demonstrated a sensitive and selective
adenosine deaminase
(
ADA
) detection by modulating the fluorescence resonance energy transfer (FRET) between cationic conjugated poly(9,9-bis(6'-N,N,N-trimethylammonium) hexyl)fluorine phenylene) (PFP) and the deoxyguanosine-tailored hairpin aptamer. The hairpin aptamer was labeled with a fluorophore
FAM
at one end and three deoxyguanosines (Gs) at the other end as a quencher. In the absence of
ADA
, aptamer forms hairpin-like conformation with adenosines making close affinity of Gs and
FAM
, which results in the weak FRET from PFP to
FAM
because of
FAM
fluorescence being quenched by Gs via photoinduced electron transfer (PET). After addition of
ADA
, adenosine was hydrolyzed by
ADA
, followed by the release of free aptamer. In this case,
FAM
being far away from Gs, the strong FRET thus was obtained due to the quenching process being blocked. Therefore, the new strategy based on the FRET ratio enhancement is reasonably used to detect the
ADA
sensitively, combining the fluorescence signal amplification of conjugated polymers with the initiative signal decreasing by Gs. The detection limit of the
ADA
assay is 0.3 U/L in both buffer solution and human serum, which is more sensitive than most of those previously documented methods. Importantly, the assay is rapid, homogeneous, and simple without a complicated treating process. The
ADA
inhibitor, erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA), was also studied based on this assay, and the detection limit of EHNA is 10 pM. This strategy provides a new platform for the detection of other biomolecules and enzymes.
...
PMID:Adenosine deaminase biosensor combining cationic conjugated polymer-based FRET with deoxyguanosine-based photoinduced electron transfer. 2536 Aug 69